Intramuscular injection as a provoking factor for paralysis in acute poliomyelitis. A case control study
Related Experiment Video
Updated: Nov 7, 2026

Direct Intrathecal Injection of Recombinant Adeno-associated Viruses in Adult Mice
Published on: February 15, 2019
N Deivanayagam1, K Nedunchelian, S S Ahamed
1Clinical Epidemiology Unit, Madras Medical College.
Abstract:
In order to identify the role of intramuscular injection (IM) as a provoking factor for poliomyelitis, a case control study as done at the Institute of Child Health, Madras from May 1988 to May 1989. The case was defined as acute poliomyelitis if he had acute asymmetric flaccid paralysis of lower motor neurone type without objective sensory disturbance following a short episode of fever. Controls were taken from children attending outpatient department for fever. Two controls matched for aged and sex were recruited for each case. Recruitment, data collection and clinical examination were done by a single pediatrician. IM injection received within 30 days prior to onset of paralysis or illness was considered to be the risk factor. The total number of cases and controls recruited were 257 and 515, respectively. Among cases, 172 (66.9%) out of 257 and among controls 252 (48.9%) out of 515, received IM injection within one month earlier to onset of paralysis or illness. The overall risk of paralysis, estimated for IM injection, was increased [odds ratio (OR) 2.1 (95% CI, 1.5-3.0)]. The maximum risk for paralysis was observed to be 2 weeks preceding the illness; the ORs for < 7 days was 2.2 (95% CI, 1.6-3.2) and for 7-13 days 3.2 (95% CI, 1.8 to 5.8). The risk of paralysis associated with IM injection was similar for unimmunized and immunized cases (OR 2.4 and 2.2). Multiple injections were not associated with a higher risk of developing paralysis.(ABSTRACT TRUNCATED AT 250 WORDS)
Insights
Intramuscular injections (IM) significantly increase the risk of developing poliomyelitis, particularly within two weeks of administration. This risk applies to both immunized and unimmunized children.
Area of Science:
- Pediatrics
- Epidemiology
- Infectious Diseases
Background:
- Poliomyelitis remains a significant public health concern.
- The role of intramuscular injections (IM) as a potential provoking factor for poliomyelitis requires investigation.
Purpose of the Study:
- To determine if intramuscular injections (IM) act as a provoking factor for acute poliomyelitis.
Main Methods:
- A case-control study was conducted with 257 poliomyelitis cases and 515 age- and sex-matched controls.
- Data on IM injections received within 30 days prior to illness onset were collected and analyzed.
- Clinical examinations and data collection were performed by a single pediatrician.
Main Results:
- Children who received IM injections within 30 days prior to paralysis onset had an increased risk of poliomyelitis (OR 2.1).
- The highest risk was observed when IM injections were given within two weeks preceding illness (ORs 2.2 to 3.2).
- The risk associated with IM injections was similar for both immunized and unimmunized children.
Conclusions:
- Intramuscular injections (IM) are identified as a significant risk factor for provoking poliomyelitis.
- Prompt medical attention is advised for children experiencing paralysis following recent IM injections.
Related Concept Videos
Poliomyelitis
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Depolarizing Blockers: Pharmocokinetics
Rabies
Diphtheria
Botulism
